Alcohol Dependence Is Associated with Blunted Dopamine Transmission in the Ventral Striatum
A decrease in dopamine type 2 receptors (D 2 ) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D 2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [ 11C]raclopride. Fifteen AD a...
Saved in:
Published in | Biological psychiatry (1969) Vol. 58; no. 10; pp. 779 - 786 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
15.11.2005
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A decrease in dopamine type 2 receptors (D
2
) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D
2
receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [
11C]raclopride.
Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D
2
receptor availability were binding potential (BP) and the equilibrium partition coefficient (V
3
″). Amphetamine-induced [
11C]raclopride displacement was measured as the difference in V
3
″ between the two scans.
[
11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [
11C]raclopride displacement was −5.2% ± 3.6% in AD subjects compared with −13.0% ± 8.8% in HC. However, no significant difference in [
11C]raclopride displacement was seen in the associative (−4.6% ± 5.8% in AD subjects vs. −6.7 ± 5.4% in HC) and sensorimotor (−12.3% ± 7.3% in AD subjects vs. −13.7 ± 7.5% in HC) subdivisions of the striatum between the two groups.
Alcohol dependence was associated with a decrease in D
2
receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only. |
---|---|
AbstractList | A decrease in dopamine type 2 receptors (D
2
) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D
2
receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [
11C]raclopride.
Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D
2
receptor availability were binding potential (BP) and the equilibrium partition coefficient (V
3
″). Amphetamine-induced [
11C]raclopride displacement was measured as the difference in V
3
″ between the two scans.
[
11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [
11C]raclopride displacement was −5.2% ± 3.6% in AD subjects compared with −13.0% ± 8.8% in HC. However, no significant difference in [
11C]raclopride displacement was seen in the associative (−4.6% ± 5.8% in AD subjects vs. −6.7 ± 5.4% in HC) and sensorimotor (−12.3% ± 7.3% in AD subjects vs. −13.7 ± 7.5% in HC) subdivisions of the striatum between the two groups.
Alcohol dependence was associated with a decrease in D
2
receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only. A decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [11C]raclopride.BACKGROUNDA decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [11C]raclopride.Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V3''). Amphetamine-induced [11C]raclopride displacement was measured as the difference in V3'' between the two scans.METHODSFifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V3''). Amphetamine-induced [11C]raclopride displacement was measured as the difference in V3'' between the two scans.[11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [11C]raclopride displacement was -5.2% +/- 3.6% in AD subjects compared with -13.0% +/- 8.8% in HC. However, no significant difference in [11C]raclopride displacement was seen in the associative (-4.6% +/- 5.8% in AD subjects vs. -6.7 +/- 5.4% in HC) and sensorimotor (-12.3% +/- 7.3% in AD subjects vs. -13.7 +/- 7.5% in HC) subdivisions of the striatum between the two groups.RESULTS[11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [11C]raclopride displacement was -5.2% +/- 3.6% in AD subjects compared with -13.0% +/- 8.8% in HC. However, no significant difference in [11C]raclopride displacement was seen in the associative (-4.6% +/- 5.8% in AD subjects vs. -6.7 +/- 5.4% in HC) and sensorimotor (-12.3% +/- 7.3% in AD subjects vs. -13.7 +/- 7.5% in HC) subdivisions of the striatum between the two groups.Alcohol dependence was associated with a decrease in D2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only.CONCLUSIONSAlcohol dependence was associated with a decrease in D2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only. Background A decrease in dopamine type 2 receptors (D sub(2)) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D sub(2) receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [ super(11)C]raclopride. Methods Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D sub(2) receptor availability were binding potential (BP) and the equilibrium partition coefficient (V sub(3)"). Amphetamine-induced [ super(11)C]raclopride displacement was measured as the difference in V sub(3)" between the two scans. Results [ super(11)C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [ super(11)C]raclopride displacement was -5.2% plus or minus 3.6% in AD subjects compared with -13.0% plus or minus 8.8% in HC. However, no significant difference in [ super(11)C] raclopride displacement was seen in the associative (-4.6% plus or minus 5.8% in AD subjects vs. -6.7 plus or minus 5.4% in HC) and sensorimotor (-12.3% plus or minus 7.3% in AD subjects vs. -13.7 plus or minus 7.5% in HC) subdivisions of the striatum between the two groups. Conclusions Alcohol dependence was associated with a decrease in D sub(2) receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only. A decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [11C]raclopride. Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V3''). Amphetamine-induced [11C]raclopride displacement was measured as the difference in V3'' between the two scans. [11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [11C]raclopride displacement was -5.2% +/- 3.6% in AD subjects compared with -13.0% +/- 8.8% in HC. However, no significant difference in [11C]raclopride displacement was seen in the associative (-4.6% +/- 5.8% in AD subjects vs. -6.7 +/- 5.4% in HC) and sensorimotor (-12.3% +/- 7.3% in AD subjects vs. -13.7 +/- 7.5% in HC) subdivisions of the striatum between the two groups. Alcohol dependence was associated with a decrease in D2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only. |
Author | Perez, Audrey Abi-Dargham, Anissa Huang, Yiyun Hwang, Dah-Ren Evans, Suzette Slifstein, Mark Krystal, John Laruelle, Marc Kegeles, Lawrence Gil, Roberto Martinez, Diana Talbot, Peter |
Author_xml | – sequence: 1 givenname: Diana surname: Martinez fullname: Martinez, Diana email: dm437@columbia.edu organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 2 givenname: Roberto surname: Gil fullname: Gil, Roberto organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 3 givenname: Mark surname: Slifstein fullname: Slifstein, Mark organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 4 givenname: Dah-Ren surname: Hwang fullname: Hwang, Dah-Ren organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 5 givenname: Yiyun surname: Huang fullname: Huang, Yiyun organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 6 givenname: Audrey surname: Perez fullname: Perez, Audrey organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 7 givenname: Lawrence surname: Kegeles fullname: Kegeles, Lawrence organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 8 givenname: Peter surname: Talbot fullname: Talbot, Peter organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 9 givenname: Suzette surname: Evans fullname: Evans, Suzette organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 10 givenname: John surname: Krystal fullname: Krystal, John organization: Department of Psychiatry, Yale University, New Haven, Connecticut – sequence: 11 givenname: Marc surname: Laruelle fullname: Laruelle, Marc organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York – sequence: 12 givenname: Anissa surname: Abi-Dargham fullname: Abi-Dargham, Anissa organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17296790$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16018986$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV1rFDEYhYNU7Lb6F8rc6N2s-ZpkBkRc-6GFghdWb7wI2cw7bNZMMk2yyv57s-xWoTcrBMILzzl5c84ZOvHBA0IXBM8JJuLter60YUpbs5pTjJs55uXwZ2hGWslqyjE9QTOMsagZpewUnaW0LqOklLxAp0Rg0natmKEfC2fCKrjqCibwPXgD1W2qFikFY3WGvvpt86r66DZ-N1yFSY_WQ3UftU-jTckGX1lf5RVU38HnqF31Ncci3Ywv0fNBuwSvDvc5-nZzfX_5ub778un2cnFXG97SXNNBsH5oOjOUBSnBTCxbzbkZhGlYz2hDZGcoLIFwoaUQg-SSAhkwl6alXLJz9GbvO8XwsIGUVVnMgHPaQ9gkJdqWNS07DpKuIVhQUcCLA7hZjtCrKdpRx616zK0Arw-ATka7oaRhbPrHSdoJ2eHCvdtzJoaUIgzK2KxzCa0kZZ0iWO3qVGv1WKfa1akwL4cXuXgi__vCMeGHvRBK7r8sRJWM3ZXb2wgmqz7Y4xbvn1gYZ70tv_0J2_8x-ANW69JF |
CODEN | BIPCBF |
CitedBy_id | crossref_primary_10_1016_j_bpsc_2015_09_005 crossref_primary_10_1111_ejn_12802 crossref_primary_10_1111_j_1530_0277_2011_01540_x crossref_primary_10_3109_10409238_2012_735642 crossref_primary_10_1016_j_nicl_2025_103762 crossref_primary_10_1111_j_1369_1600_2011_00355_x crossref_primary_10_1038_npp_2015_191 crossref_primary_10_3390_brainsci12020214 crossref_primary_10_1176_appi_ajp_2014_13121581 crossref_primary_10_1016_j_biopsych_2017_06_010 crossref_primary_10_1016_j_jbc_2021_101361 crossref_primary_10_1016_j_neubiorev_2022_104726 crossref_primary_10_1038_npp_2013_102 crossref_primary_10_1016_j_psychres_2015_07_005 crossref_primary_10_1017_neu_2013_46 crossref_primary_10_1038_npp_2013_347 crossref_primary_10_1152_physrev_00013_2008 crossref_primary_10_1038_npp_2017_131 crossref_primary_10_1016_j_biopsych_2019_03_965 crossref_primary_10_3390_nu12123834 crossref_primary_10_1097_FBP_0b013e32833dcfa5 crossref_primary_10_1002_syn_20806 crossref_primary_10_1016_j_ynirp_2024_100211 crossref_primary_10_1093_schbul_sbaa055 crossref_primary_10_1098_rstb_2008_0107 crossref_primary_10_1111_ejn_14313 crossref_primary_10_1016_j_drugalcdep_2016_01_001 crossref_primary_10_1111_j_1755_5949_2010_00161_x crossref_primary_10_1016_j_neubiorev_2020_04_004 crossref_primary_10_2139_ssrn_4109815 crossref_primary_10_1007_s00702_018_1957_2 crossref_primary_10_1007_s11307_007_0086_3 crossref_primary_10_3390_s8116936 crossref_primary_10_1111_j_1530_0277_2011_01696_x crossref_primary_10_1038_s41386_018_0191_9 crossref_primary_10_1038_s41386_018_0199_1 crossref_primary_10_1038_npp_2009_110 crossref_primary_10_1016_j_neubiorev_2013_01_018 crossref_primary_10_1523_JNEUROSCI_4322_15_2016 crossref_primary_10_1016_j_pnpbp_2015_11_004 crossref_primary_10_1177_1099800414565170 crossref_primary_10_1080_13543784_2016_1175431 crossref_primary_10_1017_neu_2013_18 crossref_primary_10_1002_da_20897 crossref_primary_10_1016_j_neuropharm_2021_108638 crossref_primary_10_1111_acer_12515 crossref_primary_10_3389_fphar_2023_1237990 crossref_primary_10_3109_02699052_2012_654591 crossref_primary_10_1016_j_gene_2022_147061 crossref_primary_10_1038_npp_2013_91 crossref_primary_10_1093_alcalc_ags047 crossref_primary_10_1111_adb_12073 crossref_primary_10_1016_j_neuropharm_2008_05_022 crossref_primary_10_1111_bcpt_70004 crossref_primary_10_1016_j_biopsych_2013_10_010 crossref_primary_10_1111_j_1530_0277_2007_00390_x crossref_primary_10_1016_j_brainres_2017_07_014 crossref_primary_10_1111_ajad_12755 crossref_primary_10_1038_npp_2008_78 crossref_primary_10_1038_s41386_021_01157_5 crossref_primary_10_1002_da_20543 crossref_primary_10_1016_j_psychres_2014_11_078 crossref_primary_10_1016_j_pscychresns_2020_111187 crossref_primary_10_1097_JGP_0b013e318170a6d1 crossref_primary_10_3109_10408363_2011_580567 crossref_primary_10_1016_j_neuroimage_2006_11_043 crossref_primary_10_3389_fnbeh_2017_00135 crossref_primary_10_1016_j_biopsych_2012_04_036 crossref_primary_10_1016_j_neuroimage_2015_03_022 crossref_primary_10_1124_jpet_109_163501 crossref_primary_10_1016_j_jad_2009_01_021 crossref_primary_10_3389_fpsyt_2022_960238 crossref_primary_10_1007_s11682_013_9233_4 crossref_primary_10_1016_j_neuroimage_2009_07_022 crossref_primary_10_1038_jcbfm_2014_209 crossref_primary_10_1007_s00213_023_06448_x crossref_primary_10_1016_j_nicl_2013_02_005 crossref_primary_10_1111_acer_12893 crossref_primary_10_1024_0939_5911_a000255 crossref_primary_10_1038_s41398_024_03083_8 crossref_primary_10_1111_adb_13022 crossref_primary_10_3389_fphar_2019_01593 crossref_primary_10_1016_j_bcp_2015_07_038 crossref_primary_10_1002_syn_22195 crossref_primary_10_1038_s41598_018_31531_1 crossref_primary_10_3389_fpsyt_2021_803208 crossref_primary_10_1038_npp_2012_232 crossref_primary_10_1016_j_bpsc_2018_03_018 crossref_primary_10_1016_j_neuropharm_2017_01_012 crossref_primary_10_1016_j_physbeh_2019_112574 crossref_primary_10_1016_j_conb_2013_05_001 crossref_primary_10_1016_j_neuropharm_2017_01_018 crossref_primary_10_1016_j_jpsychires_2022_06_036 crossref_primary_10_1124_pharmrev_121_000361 crossref_primary_10_1016_j_neuropharm_2014_05_016 crossref_primary_10_1111_bph_15210 crossref_primary_10_1016_j_biopsych_2024_09_028 crossref_primary_10_1016_j_euroneuro_2017_03_008 crossref_primary_10_1007_s00702_016_1561_2 crossref_primary_10_1038_npp_2017_223 crossref_primary_10_1016_j_neuroimage_2013_05_091 crossref_primary_10_1002_eat_20937 crossref_primary_10_1111_j_1530_0277_2006_00130_x crossref_primary_10_1155_2010_909348 crossref_primary_10_1155_2019_2030751 crossref_primary_10_1186_1756_0500_6_418 crossref_primary_10_1016_j_amp_2009_10_015 crossref_primary_10_1016_j_drugalcdep_2020_108432 crossref_primary_10_1038_s41467_025_56715_y crossref_primary_10_1111_ejn_13390 crossref_primary_10_1016_j_nicl_2020_102297 crossref_primary_10_1016_j_pharmthera_2012_01_010 crossref_primary_10_1073_pnas_1412314111 crossref_primary_10_1111_j_1530_0277_2012_01851_x crossref_primary_10_1002_ana_21364 crossref_primary_10_1007_s11469_017_9803_6 crossref_primary_10_1016_j_biopsych_2016_05_018 crossref_primary_10_1016_j_pscychresns_2007_12_001 crossref_primary_10_1177_0271678X16629483 crossref_primary_10_1016_j_neuroimage_2010_02_006 crossref_primary_10_1371_journal_pone_0099454 crossref_primary_10_1007_s00213_011_2543_6 crossref_primary_10_1080_14656566_2023_2266359 crossref_primary_10_1016_j_psychres_2020_113563 crossref_primary_10_1111_j_1530_0277_2010_01199_x crossref_primary_10_1097_HTR_0000000000000508 crossref_primary_10_1159_000362838 crossref_primary_10_1192_bjp_bp_107_041228 crossref_primary_10_1038_s41386_021_01095_2 crossref_primary_10_1016_j_neuron_2013_06_006 crossref_primary_10_2967_jnumed_111_098186 crossref_primary_10_1111_adb_13239 crossref_primary_10_1371_journal_pone_0076905 crossref_primary_10_1016_j_biopsych_2011_12_018 crossref_primary_10_1016_j_euroneuro_2013_01_009 crossref_primary_10_1038_jcbfm_2012_20 crossref_primary_10_1007_s00406_019_01072_3 crossref_primary_10_1016_j_alcohol_2020_07_004 crossref_primary_10_1038_npp_2015_110 crossref_primary_10_1016_j_pnpbp_2007_08_027 crossref_primary_10_1038_bjp_2008_101 crossref_primary_10_1515_RNS_2011_055 crossref_primary_10_1080_14459795_2018_1448428 crossref_primary_10_1111_j_1530_0277_2011_01567_x crossref_primary_10_1016_j_biopsych_2010_06_005 crossref_primary_10_1196_annals_1441_030 crossref_primary_10_1038_mp_2013_163 crossref_primary_10_1016_j_drugalcdep_2012_07_016 crossref_primary_10_1016_j_psc_2012_03_011 crossref_primary_10_1016_j_neulet_2007_11_074 crossref_primary_10_1093_alcalc_agl037 crossref_primary_10_1111_j_1369_1600_2008_00134_x crossref_primary_10_1038_npp_2014_301 crossref_primary_10_1016_j_biopsych_2011_05_035 crossref_primary_10_1523_JNEUROSCI_3371_07_2007 crossref_primary_10_3389_fphar_2014_00161 crossref_primary_10_1002_syn_20404 crossref_primary_10_1002_syn_22023 crossref_primary_10_1016_j_pbb_2014_03_006 crossref_primary_10_1016_j_neuron_2013_07_018 crossref_primary_10_1016_j_neuroimage_2017_01_045 crossref_primary_10_1038_s41386_024_01821_6 crossref_primary_10_1016_j_psychres_2019_112542 crossref_primary_10_1111_adb_13219 crossref_primary_10_1016_j_neuropharm_2013_06_031 crossref_primary_10_1038_s41386_019_0456_y crossref_primary_10_1016_j_cpr_2016_02_001 crossref_primary_10_1097_JCP_0b013e3181e75cff crossref_primary_10_1176_appi_ajp_20220819 crossref_primary_10_1016_j_pnpbp_2013_10_013 crossref_primary_10_1016_j_physbeh_2009_03_020 crossref_primary_10_1007_s00213_014_3850_5 crossref_primary_10_1016_j_dcn_2021_100944 crossref_primary_10_1016_j_mcn_2017_09_007 crossref_primary_10_1016_j_neulet_2018_08_010 crossref_primary_10_1016_j_alcohol_2007_11_004 crossref_primary_10_1080_09540260902962164 crossref_primary_10_1038_tp_2016_6 crossref_primary_10_1016_j_bbr_2016_05_045 crossref_primary_10_1111_adb_12915 crossref_primary_10_1016_j_pscychresns_2011_11_001 crossref_primary_10_1177_0269881114531664 crossref_primary_10_1111_acer_13568 crossref_primary_10_1073_pnas_1411228111 crossref_primary_10_1016_j_alcohol_2011_02_306 crossref_primary_10_1111_ejn_14160 crossref_primary_10_1111_adb_70008 crossref_primary_10_1016_j_dcn_2019_100618 crossref_primary_10_1016_j_expneurol_2019_03_012 crossref_primary_10_1016_j_neuroimage_2010_11_071 crossref_primary_10_1007_s00702_019_01985_2 crossref_primary_10_1111_psyp_14118 crossref_primary_10_1038_mp_2012_109 crossref_primary_10_1016_j_neuropharm_2013_07_039 crossref_primary_10_1002_syn_20628 crossref_primary_10_1016_j_neuroimage_2011_07_002 crossref_primary_10_1016_j_neuint_2019_01_022 crossref_primary_10_1038_s41380_018_0107_4 crossref_primary_10_1002_syn_20874 crossref_primary_10_1111_j_1360_0443_2010_03022_x crossref_primary_10_1176_appi_ps_201900561 crossref_primary_10_1176_appi_ajp_2020_19070703 crossref_primary_10_1016_j_neuroimage_2020_117154 crossref_primary_10_1073_pnas_1506012113 crossref_primary_10_1111_adb_12341 crossref_primary_10_1111_j_1530_0277_2007_00605_x crossref_primary_10_1016_j_biopsych_2006_01_008 crossref_primary_10_1002_eat_20984 crossref_primary_10_1016_j_biopsych_2022_05_024 crossref_primary_10_1016_j_euroneuro_2006_02_002 crossref_primary_10_1016_j_mehy_2005_12_003 crossref_primary_10_3389_fpsyt_2019_00626 crossref_primary_10_1177_0271678X17719390 crossref_primary_10_1016_j_drugalcdep_2019_107627 crossref_primary_10_1038_sj_npp_1301400 crossref_primary_10_1111_j_1369_1600_2008_00136_x crossref_primary_10_1093_ntr_ntab208 crossref_primary_10_1016_j_neulet_2020_135551 crossref_primary_10_1080_00952990_2016_1257633 crossref_primary_10_1016_j_mehy_2008_02_006 crossref_primary_10_1016_j_neuroimage_2014_04_060 crossref_primary_10_1002_mds_23227 crossref_primary_10_1371_journal_pone_0073903 crossref_primary_10_1016_j_biopsych_2022_03_008 crossref_primary_10_1016_j_schres_2012_07_024 crossref_primary_10_1371_journal_pone_0198935 crossref_primary_10_1038_ijo_2016_9 crossref_primary_10_1038_s41467_018_03272_2 crossref_primary_10_1038_tp_2015_139 crossref_primary_10_3389_fnbeh_2014_00141 crossref_primary_10_1016_j_alcohol_2018_05_011 crossref_primary_10_1038_npp_2015_11 crossref_primary_10_1038_s41380_018_0230_2 crossref_primary_10_1016_j_nic_2007_07_004 crossref_primary_10_1038_npp_2017_298 crossref_primary_10_1016_j_drugalcdep_2014_08_016 crossref_primary_10_1038_nrn3939 crossref_primary_10_1371_journal_pone_0171170 crossref_primary_10_3389_fpsyt_2024_1373866 crossref_primary_10_1007_s11920_011_0224_0 crossref_primary_10_1021_cn300013p crossref_primary_10_1016_j_addbeh_2020_106760 crossref_primary_10_1523_JNEUROSCI_5029_12_2013 crossref_primary_10_7202_1027830ar crossref_primary_10_1016_j_neubiorev_2017_02_010 crossref_primary_10_1038_s41598_022_25653_w crossref_primary_10_1002_syn_20734 crossref_primary_10_1016_j_euroneuro_2015_06_002 crossref_primary_10_1016_j_pharmthera_2020_107573 crossref_primary_10_1016_j_bpsc_2016_06_005 crossref_primary_10_3389_fphar_2019_01087 crossref_primary_10_1007_s00259_021_05448_3 crossref_primary_10_1111_j_1530_0277_2012_01772_x crossref_primary_10_1007_BF03033360 crossref_primary_10_1016_j_biopsych_2013_08_033 crossref_primary_10_1111_j_1530_0277_2011_01520_x crossref_primary_10_3389_fmicb_2022_916765 crossref_primary_10_1016_j_neubiorev_2018_09_010 crossref_primary_10_1038_npp_2010_237 crossref_primary_10_1111_add_12066 crossref_primary_10_1016_j_neuroimage_2007_12_063 crossref_primary_10_1038_npp_2008_104 crossref_primary_10_1016_j_biopsych_2011_08_024 crossref_primary_10_1053_j_semnuclmed_2016_09_003 crossref_primary_10_1523_JNEUROSCI_2157_21_2022 crossref_primary_10_1093_ijnp_pyv074 crossref_primary_10_1111_j_1530_0277_2007_00406_x crossref_primary_10_3389_fpsyt_2019_00176 crossref_primary_10_1016_j_mri_2007_02_017 crossref_primary_10_1016_j_physbeh_2006_03_014 crossref_primary_10_1038_s41591_023_02463_9 crossref_primary_10_1111_adb_12671 crossref_primary_10_1007_s00213_019_05345_6 crossref_primary_10_3389_fnint_2022_884080 crossref_primary_10_1002_syn_21916 crossref_primary_10_1016_j_bbi_2011_01_008 crossref_primary_10_1016_j_drugalcdep_2021_108565 crossref_primary_10_1016_j_neuroimage_2016_07_055 crossref_primary_10_1016_j_schres_2009_06_010 crossref_primary_10_1111_adb_12300 crossref_primary_10_1002_mds_27953 crossref_primary_10_1111_adb_12304 crossref_primary_10_1007_s00115_006_2067_1 crossref_primary_10_1007_s00213_014_3662_7 crossref_primary_10_3390_nu13113938 crossref_primary_10_1016_j_cell_2015_07_046 |
Cites_doi | 10.1073/pnas.90.17.7966 10.1038/sj.npp.1380111 10.1111/j.1530-0277.2001.tb02199.x 10.1176/ajp.147.6.719 10.1176/ajp.157.1.127 10.1111/j.1360-0443.2005.00960.x 10.1046/j.1471-4159.2001.00492.x 10.1016/S0969-8051(01)00214-1 10.1016/0306-4603(82)90022-3 10.1111/j.1530-0277.1995.tb01475.x 10.1016/0091-3057(82)90026-0 10.1176/appi.ajp.158.12.2015 10.1073/pnas.94.6.2569 10.1523/JNEUROSCI.12-10-03773.1992 10.1007/s002130051173 10.1038/sj.mp.4000365 10.1016/S0893-133X(96)00184-4 10.1016/0741-8329(95)00010-O 10.1097/00004647-200109000-00002 10.1002/syn.20062 10.1016/S0925-4927(02)00087-2 10.1002/ana.410440307 10.1176/ajp.161.10.1783 10.1016/0301-0082(94)90025-6 10.1016/0741-8329(93)90025-J 10.1016/S0304-3940(00)01423-3 10.1046/j.1360-0443.95.8s2.9.x 10.1016/S0006-8993(02)03220-1 10.1016/S0893-133X(97)00043-2 10.1176/ajp.127.12.1653 10.1038/sj.mp.4000859 10.1016/S0140-6736(00)03643-6 10.1007/BF02245330 10.1016/0091-3057(88)90291-2 10.1002/hbm.10129 10.1097/01.WCB.0000048520.34839.1A 10.1046/j.1471-4159.2003.01732.x 10.1037/0021-843X.91.3.199 10.1007/s00213-002-1233-9 10.1038/347146a0 10.1037/0021-843X.97.2.118 10.1002/syn.10226 10.1007/s002130050356 |
ContentType | Journal Article |
Copyright | 2005 Society of Biological Psychiatry 2006 INIST-CNRS |
Copyright_xml | – notice: 2005 Society of Biological Psychiatry – notice: 2006 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TK 7X8 |
DOI | 10.1016/j.biopsych.2005.04.044 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Neurosciences Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology |
EISSN | 1873-2402 |
EndPage | 786 |
ExternalDocumentID | 16018986 17296790 10_1016_j_biopsych_2005_04_044 S0006322305005640 |
Genre | Journal Article Comparative Study Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAAA NIH HHS grantid: R01 AA12759-0 – fundername: NCRR NIH HHS grantid: RR00645 |
GroupedDBID | --- --K --M -DZ .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABCQX ABDPE ABFNM ABFRF ABIVO ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACIEU ACIUM ACNCT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEG HMK HMO HMQ HVGLF HZ~ H~9 IHE J1W KOM L7B M29 M2V M39 M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SNS SPCBC SSH SSN SSZ T5K UAP UNMZH UPT UV1 WH7 WUQ XJT XOL Z5R ZCA ZGI ZKB ZXP ~G- AACTN AADPK AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW EFLBG G8K LCYCR RIG ZA5 AAYXX AGRNS CITATION 08R ABPIF ABPTK IQODW CGR CUY CVF ECM EIF NPM PKN 7TK 7X8 |
ID | FETCH-LOGICAL-c482t-2f63df59cf00021036b8a44cf6c53d325179c2ebe146a766f7472e1f047c82473 |
IEDL.DBID | .~1 |
ISSN | 0006-3223 |
IngestDate | Thu Jul 10 23:04:16 EDT 2025 Fri Jul 11 02:03:46 EDT 2025 Wed Feb 19 01:52:23 EST 2025 Sun Oct 22 16:05:37 EDT 2023 Thu Apr 24 23:03:50 EDT 2025 Tue Jul 01 03:21:07 EDT 2025 Fri Feb 23 02:31:31 EST 2024 Tue Aug 26 16:31:37 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | amphetamine Alcohol dependence mesolimbic positron emission tomography (PET) dopamine ventral striatum Amphetamine derivatives Radionuclide study Human Dopamine CNS stimulant Psychotropic Alcoholism Central nervous system Basal ganglion Corpus striatum Catecholamine Encephalon Chemotherapy Treatment Neurotransmitter Amfetamine Emission tomography |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c482t-2f63df59cf00021036b8a44cf6c53d325179c2ebe146a766f7472e1f047c82473 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 16018986 |
PQID | 19510626 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_68835837 proquest_miscellaneous_19510626 pubmed_primary_16018986 pascalfrancis_primary_17296790 crossref_citationtrail_10_1016_j_biopsych_2005_04_044 crossref_primary_10_1016_j_biopsych_2005_04_044 elsevier_sciencedirect_doi_10_1016_j_biopsych_2005_04_044 elsevier_clinicalkey_doi_10_1016_j_biopsych_2005_04_044 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2005-11-15 |
PublicationDateYYYYMMDD | 2005-11-15 |
PublicationDate_xml | – month: 11 year: 2005 text: 2005-11-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Biological psychiatry (1969) |
PublicationTitleAlternate | Biol Psychiatry |
PublicationYear | 2005 |
Publisher | Elsevier Inc Elsevier Science |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Science |
References | Volkow, Wang, Fowler, Logan, Hitzemann, Ding (bib42) 1996; 37 Hall, Sedvall, Magnusson, Kopp, Halldin, Farde (bib11) 1994; 11 Slifstein, Narendran, Hwang, Sudo, Talbot, Huang, Laruelle (bib34) 2004; 54 Volkow, Fowler, Wolf, Schlyer, Shiue, Alpert (bib41) 1990; 147 Hwang, Narendran, Huang, Slifstein, Talbot, Sudo (bib15) 2004; 45 Patel, Mooslehner, Chan, Emson, Stamford (bib26) 2003; 85 Boileau, Assaad, Pihl, Benkelfat, Leyton, Diksic (bib3) 2003; 49 Bradberry (bib4) 2002; 165 Mawlawi, Martinez, Slifstein, Broft, Chatterjee, Hwang (bib22) 2001; 21 Wang, Volkow, Logan, Pappas, Wong, Zhu (bib45) 2001; 357 Wang, Volkow, Fowler, Logan, Abumrad, Hitzemann (bib44) 1997; 16 Martinez, Slifstein, Broft, Mawlawi, Hwang, Huang (bib21) 2003; 23 Pennartz, Groenewegen, Lopes da Silva (bib27) 1994; 42 Anton (bib1) 2000; 95 Katner, Weiss (bib17) 2001; 25 Rousset, Ma, Evans (bib30) 1998; 39 Hietala, Kuoppamaki, Nagren, Lehikoinen, Syvalahti (bib13) 1997; 132 Sokoloff, Giros, Martres, Bouthenet, Schwartz (bib35) 1990; 347 Heinz, Siessmeier, Wrase, Hermann, Klein, Grusser (bib12) 2004; 161 Raabe, Grusser, Wessa, Podschus, Flor (bib28) 2005; 100 Laruelle, DSouza, Baldwin, AbiDargham, Kanes, Fingado (bib19) 1997; 17 Diana, Pistis, Carboni, Gessa, Rossetti (bib8) 1993; 90 Dewey, Smith, Logan, Brodie, Yu, Ferrieri (bib7) 1992; 12 Guardia, Catafau, Batlle, Martin, Segura, Gonzalvo (bib10) 2000; 157 Murphy, McBride, Lumeng, Li (bib25) 1982; 16 Tupala, Hall, Bergstrom, Mantere, Rasanen, Sarkioja, Tiihonen (bib38) 2003; 20 Casu, Dinucci, Colombo, Gessa, Pani (bib6) 2002; 948 Hietala, West, Syvalahti, Nagren, Lehikoinen, Sonninen, Ruotsalainen (bib14) 1994; 116 Skinner, Allen (bib32) 1982; 91 Gilman, Koeppe, Adams, Junck, Kluin, Johnson-Greene (bib9) 1998; 44 Repo, Kuikka, Bergstrom, Karhu, Hiltunen, Tiihonen (bib29) 1999; 147 Slifstein, Laruelle (bib33) 2001; 28 Tiihonen, Vilkman, Rasanen, Ryynanen, Hakko, Bergman (bib37) 1998; 3 Tupala, Hall, Bergstrom, Sarkioja, Rasanen, Mantere (bib39) 2001; 6 Wise (bib46) 1988; 2 McBride, Chernet, Dyr, Lumeng, Li (bib23) 1993; 10 Breier, Su, Saunders, Carson, Kolachana, deBartolomeis (bib5) 1997; 94 Volkow, Wang, Maynard, Fowler, Jayne, Telang (bib43) 2002; 116 Kuikka, Repo, Bergstrom, Tupala, Tiihonen (bib18) 2000; 292 Anton, Moak, Latham (bib2) 1995; 19 Thanos, Volkow, Freimuth, Umegaki, Ikari, Roth (bib36) 2001; 78 Murphy, McBride, Gatto, Lumeng, Li (bib24) 1988; 29 Maisto, Sobell, Cooper, Sobell (bib20) 1982; 7 Zhou, Zhang, Lumeng, Li (bib47) 1995; 12 Selzer (bib31) 1971; 127 Volkow, Chang, Wang, Fowler, Ding, Sedler (bib40) 2001; 158 Imperato, Di Chiara (bib16) 1986; 239 Katner (10.1016/j.biopsych.2005.04.044_bib17) 2001; 25 Heinz (10.1016/j.biopsych.2005.04.044_bib12) 2004; 161 Casu (10.1016/j.biopsych.2005.04.044_bib6) 2002; 948 Mawlawi (10.1016/j.biopsych.2005.04.044_bib22) 2001; 21 Patel (10.1016/j.biopsych.2005.04.044_bib26) 2003; 85 Martinez (10.1016/j.biopsych.2005.04.044_bib21) 2003; 23 Kuikka (10.1016/j.biopsych.2005.04.044_bib18) 2000; 292 Wise (10.1016/j.biopsych.2005.04.044_bib46) 1988; 2 Murphy (10.1016/j.biopsych.2005.04.044_bib24) 1988; 29 Repo (10.1016/j.biopsych.2005.04.044_bib29) 1999; 147 McBride (10.1016/j.biopsych.2005.04.044_bib23) 1993; 10 Slifstein (10.1016/j.biopsych.2005.04.044_bib34) 2004; 54 Murphy (10.1016/j.biopsych.2005.04.044_bib25) 1982; 16 Tiihonen (10.1016/j.biopsych.2005.04.044_bib37) 1998; 3 Zhou (10.1016/j.biopsych.2005.04.044_bib47) 1995; 12 Diana (10.1016/j.biopsych.2005.04.044_bib8) 1993; 90 Bradberry (10.1016/j.biopsych.2005.04.044_bib4) 2002; 165 Tupala (10.1016/j.biopsych.2005.04.044_bib38) 2003; 20 Volkow (10.1016/j.biopsych.2005.04.044_bib42) 1996; 37 Volkow (10.1016/j.biopsych.2005.04.044_bib41) 1990; 147 Slifstein (10.1016/j.biopsych.2005.04.044_bib33) 2001; 28 Volkow (10.1016/j.biopsych.2005.04.044_bib40) 2001; 158 Breier (10.1016/j.biopsych.2005.04.044_bib5) 1997; 94 Laruelle (10.1016/j.biopsych.2005.04.044_bib19) 1997; 17 Guardia (10.1016/j.biopsych.2005.04.044_bib10) 2000; 157 Hietala (10.1016/j.biopsych.2005.04.044_bib13) 1997; 132 Hietala (10.1016/j.biopsych.2005.04.044_bib14) 1994; 116 Dewey (10.1016/j.biopsych.2005.04.044_bib7) 1992; 12 Volkow (10.1016/j.biopsych.2005.04.044_bib43) 2002; 116 Anton (10.1016/j.biopsych.2005.04.044_bib2) 1995; 19 Sokoloff (10.1016/j.biopsych.2005.04.044_bib35) 1990; 347 Selzer (10.1016/j.biopsych.2005.04.044_bib31) 1971; 127 Wang (10.1016/j.biopsych.2005.04.044_bib45) 2001; 357 Hwang (10.1016/j.biopsych.2005.04.044_bib15) 2004; 45 Skinner (10.1016/j.biopsych.2005.04.044_bib32) 1982; 91 Gilman (10.1016/j.biopsych.2005.04.044_bib9) 1998; 44 Raabe (10.1016/j.biopsych.2005.04.044_bib28) 2005; 100 Pennartz (10.1016/j.biopsych.2005.04.044_bib27) 1994; 42 Wang (10.1016/j.biopsych.2005.04.044_bib44) 1997; 16 Boileau (10.1016/j.biopsych.2005.04.044_bib3) 2003; 49 Imperato (10.1016/j.biopsych.2005.04.044_bib16) 1986; 239 Tupala (10.1016/j.biopsych.2005.04.044_bib39) 2001; 6 Rousset (10.1016/j.biopsych.2005.04.044_bib30) 1998; 39 Thanos (10.1016/j.biopsych.2005.04.044_bib36) 2001; 78 Hall (10.1016/j.biopsych.2005.04.044_bib11) 1994; 11 Maisto (10.1016/j.biopsych.2005.04.044_bib20) 1982; 7 Anton (10.1016/j.biopsych.2005.04.044_bib1) 2000; 95 |
References_xml | – volume: 85 start-page: 898 year: 2003 end-page: 910 ident: bib26 article-title: Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice publication-title: J Neurochem – volume: 6 start-page: 261 year: 2001 end-page: 267 ident: bib39 article-title: Dopamine D(2)/D(3)-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics publication-title: Mol Psychiatry – volume: 90 start-page: 7966 year: 1993 end-page: 7969 ident: bib8 article-title: Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats publication-title: Proc Natl Acad Sci U S A – volume: 45 start-page: 338 year: 2004 end-page: 346 ident: bib15 article-title: Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates publication-title: J Nucl Med – volume: 42 start-page: 719 year: 1994 end-page: 761 ident: bib27 article-title: The nucleus accumbens as a complex of functionally distinct neuronal ensembles publication-title: Prog Neurobiol – volume: 116 start-page: 163 year: 2002 end-page: 172 ident: bib43 article-title: Effects of alcohol detoxification on dopamine D publication-title: Psychiatry Res – volume: 158 start-page: 2015 year: 2001 end-page: 2021 ident: bib40 article-title: Low level of brain dopamine D publication-title: Am J Psychiatry – volume: 7 start-page: 33 year: 1982 end-page: 38 ident: bib20 article-title: Comparison of two techniques to obtain retrospective reports of drinking behavior from alcohol abusers publication-title: Addict Behav – volume: 19 start-page: 92 year: 1995 end-page: 99 ident: bib2 article-title: The Obsessive Compulsive Drinking Scale publication-title: Alcohol Clin Exp Res – volume: 94 start-page: 2569 year: 1997 end-page: 2574 ident: bib5 article-title: Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations publication-title: Proc Natl Acad Sci U S A – volume: 132 start-page: 361 year: 1997 end-page: 365 ident: bib13 article-title: Effects of lorazepam administration on striatal dopamine D–2 receptor binding characteristics in man—a positron emission tomography study publication-title: Psychopharmacology – volume: 25 start-page: 198 year: 2001 end-page: 205 ident: bib17 article-title: Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and -nonpreferring rats publication-title: Alcohol Clin Exp Res – volume: 21 start-page: 1034 year: 2001 end-page: 1057 ident: bib22 article-title: Imaging human mesolimbic dopamine transmission with PET publication-title: J Cereb Blood Flow Metab – volume: 116 start-page: 285 year: 1994 end-page: 290 ident: bib14 article-title: Striatal D publication-title: Psychopharmacology (Berl) – volume: 147 start-page: 719 year: 1990 end-page: 724 ident: bib41 article-title: Effects of chronic cocaine abuse on postsynaptic dopamine receptors publication-title: Am J Psychiatry – volume: 20 start-page: 91 year: 2003 end-page: 102 ident: bib38 article-title: Dopamine D publication-title: Hum Brain Mapp – volume: 347 start-page: 146 year: 1990 end-page: 151 ident: bib35 article-title: Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics publication-title: Nature – volume: 11 start-page: 245 year: 1994 end-page: 256 ident: bib11 article-title: Distribution of D1- and D publication-title: Neuropsychopharmacology – volume: 12 start-page: 3773 year: 1992 end-page: 3780 ident: bib7 article-title: GABAergic inhibition of endogenous dopamine release measured in vivo with publication-title: J Neurosci – volume: 100 start-page: 227 year: 2005 end-page: 234 ident: bib28 article-title: The assessment of craving publication-title: Addiction – volume: 239 start-page: 219 year: 1986 end-page: 228 ident: bib16 article-title: Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol publication-title: J Pharmacol Exp Ther – volume: 17 start-page: 162 year: 1997 end-page: 174 ident: bib19 article-title: Imaging D–2 receptor occupancy by endogenous dopamine in humans publication-title: Neuropsychopharmacology – volume: 28 start-page: 595 year: 2001 end-page: 608 ident: bib33 article-title: Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers publication-title: Nucl Med Biol – volume: 54 start-page: 46 year: 2004 end-page: 63 ident: bib34 article-title: Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain publication-title: Synapse – volume: 165 start-page: 67 year: 2002 end-page: 76 ident: bib4 article-title: Dose-dependent effect of ethanol on extracellular dopamine in mesolimbic striatum of awake rhesus monkeys publication-title: Psychopharmacology (Berl) – volume: 49 start-page: 226 year: 2003 end-page: 231 ident: bib3 article-title: Alcohol promotes dopamine release in the human nucleus accumbens publication-title: Synapse – volume: 157 start-page: 127 year: 2000 end-page: 129 ident: bib10 article-title: Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients publication-title: Am J Psychiatry – volume: 16 start-page: 174 year: 1997 end-page: 182 ident: bib44 article-title: Dopamine D publication-title: Neuropsychopharmacology – volume: 23 start-page: 285 year: 2003 end-page: 300 ident: bib21 article-title: Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum publication-title: J Cereb Blood Flow Metab – volume: 948 start-page: 192 year: 2002 end-page: 202 ident: bib6 article-title: Reduced DAT- and DBH-immunostaining in the limbic system of Sardinian alcohol-preferring rats publication-title: Brain Res – volume: 161 start-page: 1783 year: 2004 end-page: 1789 ident: bib12 article-title: Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving publication-title: Am J Psychiatry – volume: 44 start-page: 326 year: 1998 end-page: 333 ident: bib9 article-title: Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[ publication-title: Ann Neurol – volume: 10 start-page: 387 year: 1993 end-page: 390 ident: bib23 article-title: Densities of dopamine D publication-title: Alcohol – volume: 3 start-page: 156 year: 1998 end-page: 161 ident: bib37 article-title: Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography publication-title: Mol Psychiatry – volume: 78 start-page: 1094 year: 2001 end-page: 1103 ident: bib36 article-title: Overexpression of dopamine D publication-title: J Neurochem – volume: 292 start-page: 57 year: 2000 end-page: 59 ident: bib18 article-title: Specific binding and laterality of human extrastriatal dopamine D2/D3 receptors in late onset type 1 alcoholic patients publication-title: Neurosci Lett – volume: 91 start-page: 199 year: 1982 end-page: 209 ident: bib32 article-title: Alcohol dependence syndrome publication-title: J Abnorm Psychol – volume: 357 start-page: 354 year: 2001 end-page: 357 ident: bib45 article-title: Brain dopamine and obesity publication-title: Lancet – volume: 2 start-page: 118 year: 1988 end-page: 132 ident: bib46 article-title: The neurobiology of craving publication-title: J Abnorm Psychol – volume: 16 start-page: 145 year: 1982 end-page: 149 ident: bib25 article-title: Regional brain levels of monoamines in alcohol-preferring and -nonpreferring lines of rats publication-title: Pharmacol Biochem Behav – volume: 127 start-page: 1653 year: 1971 end-page: 1658 ident: bib31 article-title: The Michigan alcoholism screening test publication-title: Am J Psychiatry – volume: 95 start-page: S211 year: 2000 end-page: S217 ident: bib1 article-title: Obsessive–compulsive aspects of craving publication-title: Addiction – volume: 37 start-page: 33P year: 1996 ident: bib42 article-title: Decreases in dopamine receptors but not in dopamine transporters in alcoholics publication-title: J Nucl Med – volume: 12 start-page: 403 year: 1995 end-page: 412 ident: bib47 article-title: Mesolimbic dopamine system in alcohol-preferring rats publication-title: Alcohol – volume: 39 start-page: 904 year: 1998 end-page: 911 ident: bib30 article-title: Correction for partial volume effects in PET publication-title: J Nucl Med – volume: 29 start-page: 169 year: 1988 end-page: 174 ident: bib24 article-title: Effects of acute ethanol administration on monoamine and metabolite content in forebrain regions of ethanol-tolerant and -nontolerant alcohol-preferring (P) rats publication-title: Pharmacol Biochem Behav – volume: 147 start-page: 314 year: 1999 end-page: 318 ident: bib29 article-title: Dopamine transporter and D publication-title: Psychopharmacology (Berl) – volume: 90 start-page: 7966 year: 1993 ident: 10.1016/j.biopsych.2005.04.044_bib8 article-title: Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.90.17.7966 – volume: 11 start-page: 245 year: 1994 ident: 10.1016/j.biopsych.2005.04.044_bib11 article-title: Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1380111 – volume: 25 start-page: 198 year: 2001 ident: 10.1016/j.biopsych.2005.04.044_bib17 article-title: Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and -nonpreferring rats publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.2001.tb02199.x – volume: 147 start-page: 719 year: 1990 ident: 10.1016/j.biopsych.2005.04.044_bib41 article-title: Effects of chronic cocaine abuse on postsynaptic dopamine receptors publication-title: Am J Psychiatry doi: 10.1176/ajp.147.6.719 – volume: 157 start-page: 127 year: 2000 ident: 10.1016/j.biopsych.2005.04.044_bib10 article-title: Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients publication-title: Am J Psychiatry doi: 10.1176/ajp.157.1.127 – volume: 100 start-page: 227 year: 2005 ident: 10.1016/j.biopsych.2005.04.044_bib28 article-title: The assessment of craving publication-title: Addiction doi: 10.1111/j.1360-0443.2005.00960.x – volume: 78 start-page: 1094 year: 2001 ident: 10.1016/j.biopsych.2005.04.044_bib36 article-title: Overexpression of dopamine D2 receptors reduces alcohol self-administration publication-title: J Neurochem doi: 10.1046/j.1471-4159.2001.00492.x – volume: 39 start-page: 904 year: 1998 ident: 10.1016/j.biopsych.2005.04.044_bib30 article-title: Correction for partial volume effects in PET publication-title: J Nucl Med – volume: 28 start-page: 595 year: 2001 ident: 10.1016/j.biopsych.2005.04.044_bib33 article-title: Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers publication-title: Nucl Med Biol doi: 10.1016/S0969-8051(01)00214-1 – volume: 7 start-page: 33 year: 1982 ident: 10.1016/j.biopsych.2005.04.044_bib20 article-title: Comparison of two techniques to obtain retrospective reports of drinking behavior from alcohol abusers publication-title: Addict Behav doi: 10.1016/0306-4603(82)90022-3 – volume: 19 start-page: 92 year: 1995 ident: 10.1016/j.biopsych.2005.04.044_bib2 article-title: The Obsessive Compulsive Drinking Scale publication-title: Alcohol Clin Exp Res doi: 10.1111/j.1530-0277.1995.tb01475.x – volume: 16 start-page: 145 year: 1982 ident: 10.1016/j.biopsych.2005.04.044_bib25 article-title: Regional brain levels of monoamines in alcohol-preferring and -nonpreferring lines of rats publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(82)90026-0 – volume: 158 start-page: 2015 year: 2001 ident: 10.1016/j.biopsych.2005.04.044_bib40 article-title: Low level of brain dopamine D2 receptors in methamphetamine abusers publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.158.12.2015 – volume: 94 start-page: 2569 year: 1997 ident: 10.1016/j.biopsych.2005.04.044_bib5 article-title: Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.94.6.2569 – volume: 12 start-page: 3773 year: 1992 ident: 10.1016/j.biopsych.2005.04.044_bib7 article-title: GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography publication-title: J Neurosci doi: 10.1523/JNEUROSCI.12-10-03773.1992 – volume: 147 start-page: 314 year: 1999 ident: 10.1016/j.biopsych.2005.04.044_bib29 article-title: Dopamine transporter and D2-receptor density in late-onset alcoholism publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130051173 – volume: 3 start-page: 156 year: 1998 ident: 10.1016/j.biopsych.2005.04.044_bib37 article-title: Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4000365 – volume: 16 start-page: 174 year: 1997 ident: 10.1016/j.biopsych.2005.04.044_bib44 article-title: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(96)00184-4 – volume: 12 start-page: 403 year: 1995 ident: 10.1016/j.biopsych.2005.04.044_bib47 article-title: Mesolimbic dopamine system in alcohol-preferring rats publication-title: Alcohol doi: 10.1016/0741-8329(95)00010-O – volume: 21 start-page: 1034 year: 2001 ident: 10.1016/j.biopsych.2005.04.044_bib22 article-title: Imaging human mesolimbic dopamine transmission with PET publication-title: J Cereb Blood Flow Metab doi: 10.1097/00004647-200109000-00002 – volume: 54 start-page: 46 year: 2004 ident: 10.1016/j.biopsych.2005.04.044_bib34 article-title: Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain publication-title: Synapse doi: 10.1002/syn.20062 – volume: 37 start-page: 33P year: 1996 ident: 10.1016/j.biopsych.2005.04.044_bib42 article-title: Decreases in dopamine receptors but not in dopamine transporters in alcoholics publication-title: J Nucl Med – volume: 116 start-page: 163 year: 2002 ident: 10.1016/j.biopsych.2005.04.044_bib43 article-title: Effects of alcohol detoxification on dopamine D2 receptors in alcoholics publication-title: Psychiatry Res doi: 10.1016/S0925-4927(02)00087-2 – volume: 44 start-page: 326 year: 1998 ident: 10.1016/j.biopsych.2005.04.044_bib9 article-title: Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography publication-title: Ann Neurol doi: 10.1002/ana.410440307 – volume: 161 start-page: 1783 year: 2004 ident: 10.1016/j.biopsych.2005.04.044_bib12 article-title: Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving publication-title: Am J Psychiatry doi: 10.1176/ajp.161.10.1783 – volume: 42 start-page: 719 year: 1994 ident: 10.1016/j.biopsych.2005.04.044_bib27 article-title: The nucleus accumbens as a complex of functionally distinct neuronal ensembles publication-title: Prog Neurobiol doi: 10.1016/0301-0082(94)90025-6 – volume: 239 start-page: 219 year: 1986 ident: 10.1016/j.biopsych.2005.04.044_bib16 article-title: Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol publication-title: J Pharmacol Exp Ther – volume: 10 start-page: 387 year: 1993 ident: 10.1016/j.biopsych.2005.04.044_bib23 article-title: Densities of dopamine D2 receptors are reduced in CNS regions of alcohol-preferring P rats publication-title: Alcohol doi: 10.1016/0741-8329(93)90025-J – volume: 292 start-page: 57 year: 2000 ident: 10.1016/j.biopsych.2005.04.044_bib18 article-title: Specific binding and laterality of human extrastriatal dopamine D2/D3 receptors in late onset type 1 alcoholic patients publication-title: Neurosci Lett doi: 10.1016/S0304-3940(00)01423-3 – volume: 95 start-page: S211 issue: Suppl 2 year: 2000 ident: 10.1016/j.biopsych.2005.04.044_bib1 article-title: Obsessive–compulsive aspects of craving publication-title: Addiction doi: 10.1046/j.1360-0443.95.8s2.9.x – volume: 948 start-page: 192 year: 2002 ident: 10.1016/j.biopsych.2005.04.044_bib6 article-title: Reduced DAT- and DBH-immunostaining in the limbic system of Sardinian alcohol-preferring rats publication-title: Brain Res doi: 10.1016/S0006-8993(02)03220-1 – volume: 17 start-page: 162 year: 1997 ident: 10.1016/j.biopsych.2005.04.044_bib19 article-title: Imaging D–2 receptor occupancy by endogenous dopamine in humans publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(97)00043-2 – volume: 127 start-page: 1653 year: 1971 ident: 10.1016/j.biopsych.2005.04.044_bib31 article-title: The Michigan alcoholism screening test publication-title: Am J Psychiatry doi: 10.1176/ajp.127.12.1653 – volume: 6 start-page: 261 year: 2001 ident: 10.1016/j.biopsych.2005.04.044_bib39 article-title: Dopamine D(2)/D(3)-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4000859 – volume: 357 start-page: 354 year: 2001 ident: 10.1016/j.biopsych.2005.04.044_bib45 article-title: Brain dopamine and obesity publication-title: Lancet doi: 10.1016/S0140-6736(00)03643-6 – volume: 45 start-page: 338 year: 2004 ident: 10.1016/j.biopsych.2005.04.044_bib15 article-title: Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates publication-title: J Nucl Med – volume: 116 start-page: 285 year: 1994 ident: 10.1016/j.biopsych.2005.04.044_bib14 article-title: Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02245330 – volume: 29 start-page: 169 year: 1988 ident: 10.1016/j.biopsych.2005.04.044_bib24 article-title: Effects of acute ethanol administration on monoamine and metabolite content in forebrain regions of ethanol-tolerant and -nontolerant alcohol-preferring (P) rats publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(88)90291-2 – volume: 20 start-page: 91 year: 2003 ident: 10.1016/j.biopsych.2005.04.044_bib38 article-title: Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography publication-title: Hum Brain Mapp doi: 10.1002/hbm.10129 – volume: 23 start-page: 285 year: 2003 ident: 10.1016/j.biopsych.2005.04.044_bib21 article-title: Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum publication-title: J Cereb Blood Flow Metab doi: 10.1097/01.WCB.0000048520.34839.1A – volume: 85 start-page: 898 year: 2003 ident: 10.1016/j.biopsych.2005.04.044_bib26 article-title: Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice publication-title: J Neurochem doi: 10.1046/j.1471-4159.2003.01732.x – volume: 91 start-page: 199 year: 1982 ident: 10.1016/j.biopsych.2005.04.044_bib32 article-title: Alcohol dependence syndrome publication-title: J Abnorm Psychol doi: 10.1037/0021-843X.91.3.199 – volume: 165 start-page: 67 year: 2002 ident: 10.1016/j.biopsych.2005.04.044_bib4 article-title: Dose-dependent effect of ethanol on extracellular dopamine in mesolimbic striatum of awake rhesus monkeys publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-002-1233-9 – volume: 347 start-page: 146 year: 1990 ident: 10.1016/j.biopsych.2005.04.044_bib35 article-title: Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics publication-title: Nature doi: 10.1038/347146a0 – volume: 2 start-page: 118 year: 1988 ident: 10.1016/j.biopsych.2005.04.044_bib46 article-title: The neurobiology of craving publication-title: J Abnorm Psychol doi: 10.1037/0021-843X.97.2.118 – volume: 49 start-page: 226 year: 2003 ident: 10.1016/j.biopsych.2005.04.044_bib3 article-title: Alcohol promotes dopamine release in the human nucleus accumbens publication-title: Synapse doi: 10.1002/syn.10226 – volume: 132 start-page: 361 year: 1997 ident: 10.1016/j.biopsych.2005.04.044_bib13 article-title: Effects of lorazepam administration on striatal dopamine D–2 receptor binding characteristics in man—a positron emission tomography study publication-title: Psychopharmacology doi: 10.1007/s002130050356 |
SSID | ssj0007221 |
Score | 2.3798537 |
Snippet | A decrease in dopamine type 2 receptors (D
2
) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D
2
receptors... A decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and... Background A decrease in dopamine type 2 receptors (D sub(2)) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 779 |
SubjectTerms | Addictive behaviors Adult Adult and adolescent clinical studies Alcohol dependence Alcoholism Alcoholism - diagnosis Alcoholism - diagnostic imaging Alcoholism - metabolism Alcoholism - physiopathology amphetamine Basal Ganglia - diagnostic imaging Basal Ganglia - metabolism Basal Ganglia - physiopathology Biological and medical sciences Carbon Radioisotopes Dextroamphetamine - pharmacology dopamine Dopamine - metabolism Dopamine - physiology Female Humans Limbic System - drug effects Limbic System - metabolism Limbic System - physiopathology Magnetic Resonance Imaging Male Medical sciences mesolimbic Middle Aged Neural Inhibition - drug effects Neural Inhibition - physiology Neuropharmacology Pharmacology. Drug treatments positron emission tomography (PET) Positron-Emission Tomography Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Raclopride Receptors, Dopamine D2 - drug effects Receptors, Dopamine D2 - metabolism Synaptic Transmission - drug effects Synaptic Transmission - physiology ventral striatum |
Title | Alcohol Dependence Is Associated with Blunted Dopamine Transmission in the Ventral Striatum |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0006322305005640 https://dx.doi.org/10.1016/j.biopsych.2005.04.044 https://www.ncbi.nlm.nih.gov/pubmed/16018986 https://www.proquest.com/docview/19510626 https://www.proquest.com/docview/68835837 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB5VRTwkhCBQCI-wB65u_Jh9HUNKlYLaCxRV4mDZ610pVetEJDlw4bcza-829BAVCckXWzur1c54Zr59zAfwoSosckcaaHKVEkCxWaKbnCc8rdPKYE1W5oHi6ZmYnePnC36xB9N4F8Yfqwy-v_fpnbcOX8ZhNsfL-dzf8aXwStEt5b6eJXrcjii9lR_-3h7zkHkeWPNE4lv_dUv48rCeL7pDxWFtBenBXQHq8bJa0bS5nu9id0LaBabjp_AkZJRs0g_6GezZdgD3e47JXwN4OI2UbgN4cBp20p_Dj0nPjcuOAguusexkxaK2bMP8Ci37eLVp_csRYetrEmRdbKP-_CIbm7eM8kf2vV8hZl89Bch6c_0Czo8_fZvOkkC0kBhU-TrJnSgax7VxaYcBC1GrCtE4YXjRFF1VM5OTusmtVlIIRxgkt5lLURqVoywOYL9dtPYVMIOibrK01hwdFpXSrtFSS1ugy4zQ9RB4nN3ShCrkngzjqozHzS7LqBVPkcnLFOnBIYxv5JZ9HY47JWRUXhlvmZJfLClU3CmpbyRv2eI_yY5u2cl2sIRihNTpEN5HwylJW357pmrtYrMqM5_sEr7c3UIoypdVIYfwsre4be-Eq5VW4vV_DP0NPOrr0mZJxt_C_vrnxr6jjGtdj7pfagT3JidfZmd_AD6_Klg |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB4hqpZKqGq3D5a24EOvYR3Hj_gIS9HSslwKFVIPVuLY0iLIrrq7By789o4Thy2HFZUq-ZIoY1meycx8fswH8KXIHBceNVCxnCJAcWmiKyYSQUtaWF6ilQWgOD6Xo0v-7UpcbcCwuwsTjlVG39_69MZbxzeDOJuD2WQS7vhieMXoRkWoZ8kRtz_j-PsGGoOD-9U5D8VYpM2TSfj8r2vC1wflZNqcKo6LKxwbXxehtmfFHOfNt4QX6zPSJjKdvIZXMaUkh-2o38CGq3vwvCWZvOvB1rDjdOvBi3HcSn8Lvw5bclxyHGlwrSOnc9Kpy1UkLNGSo5tlHR6OEVzfoiBpghv2F1bZyKQmmECSn-0SMfkROEAWy9t3cHny9WI4SiLTQmJ5zhYJ8zKrvNDW0wYEZrLMC86tl1ZkVdaUNbMM9Y1-tVBSegQhzKWecmVzxlX2Hjbrae12gFguyyqlpRbc86zIta-00spl3KdW6rIPoptdY2MZ8sCGcWO682bXptNK4MgUhnJsvA-DB7lZW4jjSQnVKc9010zRMRqMFU9K6gfJR8b4T7J7j-xkNViEMVJp2of9znAMaivszxS1my7nJg3ZLgLM9V_IHBPmPFN9-NBa3Kp3BNa5zuXufwx9H7ZGF-Mzc3Z6_v0jvGyL1KZJKj7B5uL30n3G9GtR7jW_1x_K9ivm |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alcohol+dependence+is+associated+with+blunted+dopamine+transmission+in+the+ventral+striatum&rft.jtitle=Biological+psychiatry+%281969%29&rft.au=MARTINEZ%2C+Diana&rft.au=GIL%2C+Roberto&rft.au=LARUELLE%2C+Marc&rft.au=ABI-DARGHAM%2C+Anissa&rft.date=2005-11-15&rft.pub=Elsevier+Science&rft.issn=0006-3223&rft.eissn=1873-2402&rft.volume=58&rft.issue=10&rft.spage=779&rft.epage=786&rft_id=info:doi/10.1016%2Fj.biopsych.2005.04.044&rft.externalDBID=n%2Fa&rft.externalDocID=17296790 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-3223&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-3223&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-3223&client=summon |